The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.
Supported by
The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.
By Dani Blum
Reporting from the American Diabetes Association Scientific Sessions in Chicago.
Doctors call the new weight-loss drugs revolutionary. Game-changing. Unprecedented.
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could…
Eli Lilly’s orforglipron could offer needle-free alternative to weight-loss jabs at lower cost
Here’s how retatrutide works and how it differs from existing weight management medications.
People taking the new wonder drug orforglipron lost an average of 12.4 per cent of their body weight after 72 weeks and benefited…
A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side…
An experimental GLP-1 pill called orforglipron promoted substantial weight loss without the need for weekly injections, clinical…
